Stephen Caldwell headshot

Stephen H. Caldwell

Unit: School of Medicine
Department: Department of Medicine, Gastroenterology
Office location and address
Digestive Health Center
1335 Lee St
Charlottesville, Virginia 22903
Residency, Roanoke Memorial Hospital
Fellowship, Gastroenterology, University of Virginia
MD, Wake Forest University School of Medicine
Fellowship, Hepatology, University of Miami

Stephen Caldwell, MD, is a hepatologist specializing in a nonalcoholic steatohepatitis (NASH), including its relationship to so-called cryptogenic cirrhosis, ethnic and familial relationships and the role of mitochondrial dysfunction in the disease. He and his colleagues pioneered work on cellular ballooning and the role of small fat droplets in NASH and have also worked extensively with cyanoacrylates in the treatment of gastric variceal bleeding. He is overseeing a number of treatment trials for NASH and a variety of other liver diseases and is closely involved with a network of physicians and scientists working with coagulation disorders in liver disease.

Dr. Caldwell is a native of Statesville, NC. He earned his medical degree from Wake Forest University Medical School. Dr. Caldwell completed his medical residency at a University of Virginia-affiliated program in Roanoke and Salem, VA, where he served as chief resident in his final year. He completed a gastroenterology fellowship program at UVA and a hepatology fellowship at the University of Miami. In 1992, he joined the faculty at UVA, helping to develop the hepatology program.

Now a professor of medicine in the Division of Gastroenterology and Hepatology, Dr. Caldwell is board-certified in internal medicine and gastroenterology.

November 20, 2020 – November 19, 2023
A Phase 2 Study to Evaluate the Efficacy and Safety of Elafibranor at doses of 80 mg and 120mg After 12 Weeks of Treatment in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
Source: Genfit
June 15, 2017 – June 14, 2020
Coagulation in Liver Disease - Symposium 8
Source: Dova Pharmaceuticals, Inc.
January 09, 2019 – December 31, 2019
Evaluating the Safety & Efficacy of GS-6624
Source: Gilead Sciences, Inc.
January 24, 2013 – September 30, 2017
Commonwealth Foundation for Cancer Research
Source: Commonwealth Cancer Foundation for Research
June 01, 2002 – December 31, 2015
MD-INMD An Observational Study to Assess Documentation of Hepatic Encephalopathy in Clinical Practice
Source: Syneos Health, LLC
January 28, 2015 – September 26, 2015
Omega 3 Fatty Acids Effect in Nonalcoholic Steatohepatitis
Source: Wellstat Diagnostics, LLC
February 05, 2011 – July 31, 2013

2011-2018 Best Doctors in America® List